Evidences suggest that kallikreins are involved in tumor progression and distinct kallikreins are applied as tumor marker in cancer diagnosis, for example, kallikrein hK3 also known as prostate-specific antigen [48, 49]. This evidence concerns the gene KLK3 and neoplasm.